Physician profile
Yan Duan
NPI 1770504763
$1,859.50
in general payments reported to CMS, 2019-2025
7 companies · $328 in 2025
The $328 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $663 · 2022: $412 · 2023: $323 · 2024: $133 · 2025: $328.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $776 · Education: $8.45.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $776.35 |
| Education | $8.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $1,015.32 | 2021-2025 | Xeomin |
| Abbvie INC. | $478.20 | 2023-2025 | |
| Galderma Laboratories, L.P. | $202.66 | 2021-2025 | |
| Allergan, INC. | $69.92 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $35.55 | 2022-2023 | Jardiance |
| Lilly USA, LLC | $30.67 | 2022 | |
| Edwards Lifesciences Corporation | $27.18 | 2024 | Edwards Sapien Xt Transcatheter Heart Valve (Thv) |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yan Duan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.